Sclerosing epithelioid fibrosarcoma of the pancreas: A case report

Table 1 Summary of clinical data on reported pancreatic sclerosing epithelioid fibrosarcoma in the literature

No.	Year	Ref.	Gender	Age	Location	Size (cm)	Clinical presentation	Surgical procedure	IHC	Ki-67 index	Follow up (m)	Recurrence
1	2013	Bai et al[8]	M	67	Body	1	None	DP and splenectomy	Vimentin (+), EMA (-), SMA (-), S-100 protein (-)	< 5%	NM	NM
2	2014	Luo et al[11]	M	42	Head	2.9	Upper abdominal pain	PD	Vimentin (+), SMA (-), S-100 protein (-), bcl-2 (-)	15%	16	None
3	2020	Xia et al[10]	M	64	Tail	2	None	DP and splenectomy	Vimentin (+), bcl-2 (+), EMA (+), SMA (+), CD34 (-), S-100 protein (-)	8% (+)	12	None
4	2020	Kramer et al[9]	M	58	Head	6	None	PPPD	MUC4 (+)	NM	3	None
5	2024	Present case	M	33	Head	8	Upper abdominal pain	Laparoscopic PPPD	MUC4 (+), Vimentin (+), SMA (-), S-100 protein (scattered +), CD34 (vessel +)	30%	2	None

IHC: Immunohistochemistry; DP: Distal pancreatectomy; CD: Cluster of differentiation; PD: pancreaticoduodenectomy; PPPD: Pylorus-preserving pancreaticoduodenectomy; NM: Not mentioned; EMA: Epithelial membrane antigen; SMA: Smooth muscle actin.